• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[A case report of paclitaxel combined with carboplatin for poorly differentiated prostate cancer with renal failure].

作者信息

Chen Ji-Wen, Meng Qing-Gui, Tang Yong, Xie Dong, Wang Zhi-Rou

机构信息

Department of Urology,Cancer Hospital,Guangxi Medical University,Nanning, Guangxi, 530021,P. R. China.

出版信息

Ai Zheng. 2007 Apr;26(4):445-6.

PMID:17430671
Abstract
摘要

相似文献

1
[A case report of paclitaxel combined with carboplatin for poorly differentiated prostate cancer with renal failure].紫杉醇联合卡铂治疗伴肾衰竭的低分化前列腺癌1例报告
Ai Zheng. 2007 Apr;26(4):445-6.
2
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.多中心2期研究：新辅助紫杉醇、磷酸雌莫司汀和卡铂联合雄激素剥夺疗法用于高危局限性前列腺癌患者放疗前的治疗——癌症与白血病B组99811研究结果
Cancer. 2008 Dec 1;113(11):3137-45. doi: 10.1002/cncr.23910.
3
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.干扰素γ-1b联合标准卡铂/紫杉醇与单纯卡铂/紫杉醇一线治疗晚期卵巢癌和原发性腹膜癌的随机3期试验：无进展生存期前瞻性设计分析结果
Gynecol Oncol. 2008 May;109(2):174-81. doi: 10.1016/j.ygyno.2008.01.005. Epub 2008 Mar 7.
4
[Successful treatment of primary peritoneal carcinoma with paclitaxel and carboplatin combination chemotherapy].紫杉醇联合卡铂化疗成功治疗原发性腹膜癌
Gan To Kagaku Ryoho. 2008 Jan;35(1):153-5.
5
Editorial comment on: Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
Eur Urol. 2007 Oct;52(4):1122. doi: 10.1016/j.eururo.2007.03.079.
6
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.一项随机III期研究，比较每周紫杉醇联合卡铂与卡铂和紫杉醇每3周标准给药方案用于既往未治疗的晚期非小细胞肺癌患者的疗效。
J Clin Oncol. 2008 Jan 20;26(3):468-73. doi: 10.1200/JCO.2007.13.1912.
7
Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.紫杉醇联合卡铂诱导化疗后序贯紫杉醇同步放疗用于ⅢB期非小细胞肺癌（NSCLC）患者：一项Ⅱ期试验
Lung Cancer. 2007 Nov;58(2):238-45. doi: 10.1016/j.lungcan.2007.06.003. Epub 2007 Jul 20.
8
Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.在铂类方案治疗失败后，每周使用紫杉醇和卡铂治疗晚期移行细胞癌。
Eur Urol. 2007 Oct;52(4):1115-22. doi: 10.1016/j.eururo.2007.03.078. Epub 2007 Apr 5.
9
[Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].每周一次卡铂和紫杉醇联合同步放疗治疗局部晚期非小细胞肺癌的临床研究
Gan To Kagaku Ryoho. 2009 Oct;36(10):1653-6.
10
Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.在初治的晚期或转移性非小细胞肺癌患者中比较卡铂、紫杉醇和贝沙罗汀与卡铂和紫杉醇的III期试验：SPIRIT II
J Clin Oncol. 2008 Apr 10;26(11):1879-85. doi: 10.1200/JCO.2007.12.2689.